{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T17:12:48Z","timestamp":1793121168514,"version":"4.5.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:00:00Z","timestamp":1734480000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","thegreenjournal.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.radonc.2024.110689","type":"journal-article","created":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T16:26:54Z","timestamp":1734539214000},"page":"110689","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Predictive biomarkers of radiotherapy- related dermatitis, xerostomia, mucositis and dysphagia in head and neck cancer: A systematic review"],"prefix":"10.1016","volume":"203","author":[{"given":"Alexander","family":"Koch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Reinhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olgun","family":"Elicin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel M.","family":"Aebersold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5189-0507","authenticated-orcid":false,"given":"Daniel H.","family":"Schanne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2024.110689_b0005","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s10552-019-01185-z","article-title":"Treatment trends in head and neck cancer: Surveillance, Epidemiology, and End Results (SEER) Patterns of Care analysis","volume":"30","author":"Schlichting","year":"2019","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.radonc.2024.110689_b0010","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S1470-2045(07)70144-4","article-title":"TAME: development of a new method for summarising adverse events of cancer treatment by the Radiation Therapy Oncology Group","volume":"8","author":"Trotti","year":"2007","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2024.110689_b0015","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.critrevonc.2017.10.011","article-title":"Incidence of skin toxicity in squamous cell carcinoma of the head and neck treated with radiotherapy and cetuximab: A systematic review","volume":"120","author":"Bonomo","year":"2017","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.radonc.2024.110689_b0020","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.radonc.2021.01.024","article-title":"Comprehensive toxicity risk profiling in radiation therapy for head and neck cancer: A new concept for individually optimised treatment","volume":"157","author":"Van den Bosch","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110689_b0025","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1001\/jamaoncol.2023.0444","article-title":"Bacterial Decolonization for Prevention of Radiation Dermatitis: A Randomized Clinical Trial","volume":"9","author":"Kost","year":"2023","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.radonc.2024.110689_b0030","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/1440-1681.12738","article-title":"Impact of polymorphisms in angiogenesis-related genes on clinical outcomes of radiotherapy in patients with nasopharyngeal carcinoma","volume":"44","author":"Ma","year":"2017","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.radonc.2024.110689_b0035","doi-asserted-by":"crossref","first-page":"42","DOI":"10.4103\/jcrt.JCRT_344_20","article-title":"Serum zinc status and the development of mucositis and dermatitis in head-and-neck cancer patients undergoing curative radiotherapy: A pilot study","volume":"18","author":"Rao","year":"2022","journal-title":"J Cancer Res Ther"},{"key":"10.1016\/j.radonc.2024.110689_b0040","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1007\/s00520-020-05805-2","article-title":"Salivary alpha-1-antitrypsin and macrophage migration inhibitory factor may be potential prognostic biomarkers for oncologic treatment-induced severe oral mucositis","volume":"29","author":"Palmier","year":"2021","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.radonc.2024.110689_b0045","doi-asserted-by":"crossref","first-page":"5124","DOI":"10.1002\/cncr.33161","article-title":"Oral microbiome and onset of oral mucositis in patients with squamous cell carcinoma of the head and neck","volume":"126","author":"Reyes-Gibby","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2024.110689_b0050","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/1748-717X-8-155","article-title":"Correlation of dynamic changes in \u03b3-H2AX expression in peripheral blood lymphocytes from head and neck cancer patients with radiation-induced oral mucositis","volume":"8","author":"Li","year":"2013","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2024.110689_b0055","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16050949","article-title":"Single Nucleotide Polymorphisms as Biomarker Predictors of Oral Mucositis Severity in Head and Neck Cancer Patients Submitted to Combined Radiation Therapy and Chemotherapy: A Systematic Review","volume":"16","author":"Cavalieri","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/j.radonc.2024.110689_b0060","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1007\/s00066-024-02237-3","article-title":"Potential Single Nucleotide Polymorphisms markers for radiation dermatitis in head and neck cancer patients: a meta-analysis","volume":"200","author":"Aguiar","year":"2024","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.radonc.2024.110689_b0065","doi-asserted-by":"crossref","first-page":"5168","DOI":"10.3390\/curroncol30050391","article-title":"Investigating Predictive Factors of Dysphagia and Treatment Prolongation in Patients with Oral Cavity or Oropharyngeal Cancer Receiving Radiation Therapy Concurrently with Chemotherapy","volume":"30","author":"Alexidis","year":"2023","journal-title":"Curr Oncol"},{"key":"10.1016\/j.radonc.2024.110689_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2023.106386","article-title":"Machine learning for the prediction of toxicities from head and neck cancer treatment: A systematic review with meta-analysis","volume":"140","author":"Ara\u00fajo","year":"2023","journal-title":"Oral Oncol"},{"key":"10.1016\/j.radonc.2024.110689_b0075","doi-asserted-by":"crossref","first-page":"W207","DOI":"10.1093\/nar\/gkad347","article-title":"g:Profiler-interoperable web service for functional enrichment analysis and gene identifier mapping (2023 update)","volume":"51","author":"Kolberg","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.radonc.2024.110689_b0080","article-title":"Z-curve 2.0: Estimating Replication Rates and Discovery Rates","volume":"6","author":"Barto\u0161","year":"2022","journal-title":"Mol Pathol"},{"key":"10.1016\/j.radonc.2024.110689_b0085","doi-asserted-by":"crossref","first-page":"280","DOI":"10.7326\/0003-4819-158-4-201302190-00009","article-title":"Assessing bias in studies of prognostic factors","volume":"158","author":"Hayden","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.radonc.2024.110689_b0090","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s41512-019-0050-0","article-title":"Elaborating on the assessment of the risk of bias in prognostic studies in pain rehabilitation using QUIPS-aspects of interrater agreement","volume":"3","author":"Grooten","year":"2019","journal-title":"Diagn Progn Res"},{"key":"10.1016\/j.radonc.2024.110689_b0095","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.radonc.2024.110689_b0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002742","article-title":"COSMOS-E: Guidance on conducting systematic reviews and meta-analyses of observational studies of etiology","volume":"16","author":"Dekkers","year":"2019","journal-title":"PLoS Med"},{"key":"10.1016\/j.radonc.2024.110689_b0105","unstructured":"PROSPERO. International prospective register of systematic reviews https:\/\/www.crd.york.ac.uk\/prospero\/display_record.php?RecordID=361245."},{"key":"10.1016\/j.radonc.2024.110689_b0110","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.lungcan.2019.12.005","article-title":"Next-generation sequencing informs diagnosis and identifies unexpected therapeutic targets in lung squamous cell carcinomas","volume":"140","author":"Sands","year":"2020","journal-title":"Lung Cancer"},{"key":"10.1016\/j.radonc.2024.110689_b0115","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.clpt.2006.06.007","article-title":"A pharmacokinetic-based test to prevent severe 5-fluorouracil toxicity","volume":"80","author":"Bocci","year":"2006","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.radonc.2024.110689_b0120","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.lungcan.2022.01.021","article-title":"Genomic testing among patients with newly diagnosed advanced non-small cell lung cancer in the United States: A contemporary clinical practice patterns study","volume":"167","author":"Paz-Ares","year":"2022","journal-title":"Lung Cancer"},{"key":"10.1016\/j.radonc.2024.110689_b0125","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1056\/NEJMoa043331","article-title":"MGMT gene silencing and benefit from temozolomide in glioblastoma","volume":"352","author":"Hegi","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2024.110689_b0130","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jbiotec.2023.12.005","article-title":"Routine molecular applications and recent advances in breast cancer diagnostics","volume":"380","author":"Pankotai-Bod\u00f3","year":"2024","journal-title":"J Biotechnol"},{"key":"10.1016\/j.radonc.2024.110689_b0135","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/j.ebiom.2015.10.024","article-title":"Radiation-induced CD8 T-lymphocyte Apoptosis as a Predictor of Breast Fibrosis After Radiotherapy: Results of the Prospective Multicenter French Trial","volume":"2","author":"Azria","year":"2015","journal-title":"EBioMedicine"},{"key":"10.1016\/j.radonc.2024.110689_b0140","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10123288","article-title":"Prognostic and Predictive Biomarkers in Head and Neck Squamous Cell Carcinoma Treated with Radiotherapy-A Systematic Review","volume":"10","author":"Schanne","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.radonc.2024.110689_b0145","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.dnarep.2015.02.005","article-title":"The structural basis of XRCC1-mediated DNA repair","volume":"30","author":"London","year":"2015","journal-title":"DNA Repair"},{"key":"10.1016\/j.radonc.2024.110689_b0150","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.lungcan.2008.02.019","article-title":"XRCC1 polymorphisms and severe toxicity in lung cancer patients treated with cisplatin-based chemotherapy in Chinese population","volume":"62","author":"Wang","year":"2008","journal-title":"Lung Cancer"},{"key":"10.1016\/j.radonc.2024.110689_b0155","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.lungcan.2008.11.014","article-title":"Polymorphisms in XRCC1 and XPG and response to platinum-based chemotherapy in advanced non-small cell lung cancer patients","volume":"65","author":"Sun","year":"2009","journal-title":"Lung Cancer"},{"key":"10.1016\/j.radonc.2024.110689_b0160","doi-asserted-by":"crossref","first-page":"43786","DOI":"10.1007\/s11356-020-10270-9","article-title":"Genetic polymorphisms in XRCC1, OGG1, and XRCC3 DNA repair genes and DNA damage in radiotherapy workers","volume":"27","author":"Soliman","year":"2020","journal-title":"Environ Sci Pollut Res Int"},{"key":"10.1016\/j.radonc.2024.110689_b0165","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s41548-019-00021-x","article-title":"XRCC1 (rs25487) polymorphism is associated with severe oral mucositis and poor treatment response after radiotherapy for oropharyngeal carcinoma","volume":"3","author":"Gupta","year":"2019","journal-title":"Oral Cancer"},{"key":"10.1016\/j.radonc.2024.110689_b0170","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.ijrobp.2004.12.027","article-title":"Radiation-induced damage to normal tissues after radiotherapy in patients treated for gynecologic tumors: association with single nucleotide polymorphisms in XRCC1, XRCC3, and OGG1 genes and in vitro chromosomal radiosensitivity in lymphocytes","volume":"62","author":"De Ruyck","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2024.110689_b0175","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1056\/NEJMoa060570","article-title":"DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy","volume":"355","author":"Olaussen","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2024.110689_b0180","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1200\/JCO.2007.11.3167","article-title":"ERCC1-tailored chemotherapy in lung cancer: the first prospective randomized trial","volume":"25","author":"Soria","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2024.110689_b0185","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1093\/annonc\/mdw235","article-title":"ESMO consensus guidelines for the management of patients with metastatic colorectal cancer","volume":"27","author":"Van Cutsem","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.radonc.2024.110689_b0190","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1080\/15216540701736285","article-title":"Role of the MRP1\/ABCC1 multidrug transporter protein in cancer","volume":"59","author":"Munoz","year":"2007","journal-title":"IUBMB Life"},{"key":"10.1016\/j.radonc.2024.110689_b0195","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1756-8722-5-47","article-title":"Detection of ABCC1 expression in classical Hodgkin lymphoma is associated with increased risk of treatment failure using standard chemotherapy protocols","volume":"5","author":"Greaves","year":"2012","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.radonc.2024.110689_b0200","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1002\/ijc.27567","article-title":"A comprehensive study of polymorphisms in ABCB1, ABCC2 and ABCG2 and lung cancer chemotherapy response and prognosis","volume":"131","author":"Campa","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1016\/j.radonc.2024.110689_b0205","doi-asserted-by":"crossref","first-page":"6683","DOI":"10.1158\/1078-0432.CCR-07-4389","article-title":"IL12RB2 and ABCA1 genes are associated with susceptibility to radiation dermatitis","volume":"14","author":"Isomura","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.radonc.2024.110689_b0210","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1124\/pr.115.011833","article-title":"Endothelin","volume":"68","author":"Davenport","year":"2016","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.radonc.2024.110689_b0215","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1667\/RR0780.1","article-title":"Low-dose ionizing radiation stimulates transcription and production of endothelin by human vein endothelial cells","volume":"168","author":"Lanza","year":"2007","journal-title":"Radiat Res"},{"key":"10.1016\/j.radonc.2024.110689_b0220","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.ijrobp.2008.12.086","article-title":"Up-regulation of endothelin type a receptor in human and rat radiation proctitis: preclinical therapeutic approach with endothelin receptor blockade","volume":"74","author":"Jullien","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2024.110689_b0225","doi-asserted-by":"crossref","first-page":"72939","DOI":"10.18632\/oncotarget.18513","article-title":"GSTP1 polymorphism predicts treatment outcome and toxicities for breast cancer","volume":"8","author":"Ma","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.radonc.2024.110689_b0230","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/ijc.23138","article-title":"Genetic predictors of long-term toxicities after radiation therapy for breast cancer","volume":"122","author":"Kuptsova","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.radonc.2024.110689_b0235","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.738230","article-title":"DNA Double Strand Break Repair Pathways in Response to Different Types of Ionizing Radiation","volume":"12","author":"van de Kamp","year":"2021","journal-title":"Front Genet"},{"key":"10.1016\/j.radonc.2024.110689_b0240","doi-asserted-by":"crossref","first-page":"5834","DOI":"10.1038\/sj.onc.1206682","article-title":"DNA damage checkpoint control in cells exposed to ionizing radiation","volume":"22","author":"Iliakis","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.radonc.2024.110689_b0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113854","article-title":"Lack of predictive tools for conventional and targeted cancer therapy: Barriers to biomarker development and clinical translation","volume":"176","author":"Batis","year":"2021","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.radonc.2024.110689_b0250","article-title":"STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies","volume":"351","author":"Bossuyt","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.radonc.2024.110689_b0255","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.radonc.2024.110689_b0260","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/jnci\/djy088","article-title":"Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): An abridged explanation and elaboration","volume":"110","author":"Sauerbrei","year":"2018","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.radonc.2024.110689_b0265","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s12916-022-02304-5","article-title":"Structured reporting to improve transparency of analyses in prognostic marker studies","volume":"20","author":"Sauerbrei","year":"2022","journal-title":"BMC Med"},{"key":"10.1016\/j.radonc.2024.110689_b0270","unstructured":"EORTC-European Organization for Research and Treatment of Cancer. E2-RADIatE. E2-RADIatE https:\/\/project.eortc.org\/e2-radiate\/ (2019)."},{"key":"10.1016\/j.radonc.2024.110689_b0275","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001381","article-title":"Prognosis Research Strategy (PROGRESS) 3: prognostic model research","volume":"10","author":"Steyerberg","year":"2013","journal-title":"PLoS Med"},{"key":"10.1016\/j.radonc.2024.110689_b0280","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1186\/s12874-022-01801-8","article-title":"Methodological guidance for the evaluation and updating of clinical prediction models: a systematic review","volume":"22","author":"Binuya","year":"2022","journal-title":"BMC Med Res Method"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814024043512?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814024043512?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T17:57:12Z","timestamp":1741888632000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814024043512"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":56,"alternative-id":["S0167814024043512"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2024.110689","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictive biomarkers of radiotherapy- related dermatitis, xerostomia, mucositis and dysphagia in head and neck cancer: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2024.110689","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"110689"}}